Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Pre-Blend Dose Assessment (10 units / 0.10 mL daily) Component GHK-Cu Per-dose from Blend ~1.67 mg Typical Standalone 1-2 mg daily Assessment In range Component BPC-157 Per-dose from Blend ~0.33 mg Typical Standalone 0.25-0.5 mg daily Assessment In range Component TB-500 Per-dose from Blend ~0.33 mg Typical Standalone 2-5 mg per injection, 2x/week Assessment Below standalone injury range The 5:1:1 blend is convenience- and skin-focused
No Disease Claims: This compound is not intended to diagnose, treat, cure, or prevent any disease
By lowering eosinophil levels, benralizumab helps decrease asthma symptoms, asthma exacerbations, improve forced expiratory volume (FEV1), and reduce reliance on oral corticosteroids
The solution might look fine after shaking
Successful outcomes require allowing healing to outpace further injury
